Valeant Pharmaceuticals Weighed Replacing CEO

Wall Street Journal-20 hours ago

Some pharmacy-benefit managers, which are firms that pay for drugs on behalf of clients, were threatening to abandon Valeant's more-expensive products, after ...

Valeant under pressure to beef up management as new board meets
Reuters-18 hours ago

Explore in depth (130 more articles)